PSYGF Stock: Psyence Group Inc. Stock Price, Analysis & Insights

Get live PSYGF stock price $0.13, comprehensive Psyence Group Inc. stock analysis, charts, news, and expert forecast. Real-time PSYGF stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

0.13

0.00%Today

PSYGF • Psyence Group Inc. • Other OTC • Healthcare

Market Cap

1.99M

Volume

100

52W High

0.14

52W Low

0.10

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Psyence Group Inc. is a biotechnology firm operating in the life sciences sector, primarily focused on the commercial cultivation and production of psilocybin mushrooms. The company's naturally derived psilocybin is intended for therapeutic applicati...

Contact Information

Website: https://www.psyence.com
Address: 200 Bay Street
Country: CA

Investment Analysis & Business Insights

Healthcare

Drug Manufacturers - General

Investment Highlights

✓ Strong presence in the Healthcare sector with established market position

✓ Lower volatility stock (Beta: -0.81) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Psyence Group Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Healthcare may affect company performance
⚠Past performance does not guarantee future results for Psyence Group Inc.
⚠Investors should consider how Psyence Group Inc. fits within their overall portfolio allocation
⚠Valuation metrics suggest potential, but require fundamental analysis

Market Cap

1.99M

P/E Ratio (TTM)

-0.17

Beta

-0.81

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

Related Stocks

Compare PSYGF with peer companies:

Ayala Pharmaceuticals, Inc. (ADXS)

Price: $0.60
Market cap: 25.71M

Aion Therapeutic Inc. (ANTCF)

Price: $0.00
Market cap: 2.07M

Cryomass Technologies Inc. (CRYM)

Price: $0.00
Market cap: 47.43K

Genix Pharmaceuticals Corporation (GENPF)

Price: $0.01
Market cap: 863.26K

Indo Global Exchange(s) PTE, Ltd. (IGEX)

Price: $0.00
Market cap: 2.64M

Kaya Holdings, Inc. (KAYS)

Price: $0.02
Market cap: 829.38K

Resonate Blends, Inc. (KOAN)

Price: $0.00
Market cap: 175.72K

Restart Life Sciences Corp. (NMLSF)

Price: $0.07
Market cap: 2.68M

ReNeuron Group plc (RNUGF)

Price: $0.00
Market cap: 62.89K

TILT Holdings Inc. (TLLTF)

Price: $0.00
Market cap: 34.75K

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.